OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced on its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC. Orchestra creates AI agents that help biotech companies manage…
